279 related articles for article (PubMed ID: 3279318)
1. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
Madsen JC; Superina RA; Wood KJ; Morris PJ
Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunological unresponsiveness using recipient cells transfected with donor class I or class II MHC genes.
Madsen JC; Wood KJ; Superina RA; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):477. PubMed ID: 2495614
[No Abstract] [Full Text] [Related]
3. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo.
Bell Y; Shoskes D; Morris P; Wood K
Transplant Proc; 1993 Feb; 25(1 Pt 1):359. PubMed ID: 8438334
[No Abstract] [Full Text] [Related]
4. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo.
Fry JW; Morris PJ; Wood KJ
Gene Ther; 2002 Feb; 9(3):220-6. PubMed ID: 11859426
[TBL] [Abstract][Full Text] [Related]
6. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
[TBL] [Abstract][Full Text] [Related]
7. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex.
Knechtle SJ; Wang J; Jiao S; Geissler EK; Sumimoto R; Wolff J
Transplantation; 1994 Apr; 57(7):990-6. PubMed ID: 8165719
[TBL] [Abstract][Full Text] [Related]
8. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.
Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ
Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548
[TBL] [Abstract][Full Text] [Related]
9. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
10. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
Saitovitch D; Morris PJ; Wood KJ
Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
[TBL] [Abstract][Full Text] [Related]
11. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
[TBL] [Abstract][Full Text] [Related]
12. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
13. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
[TBL] [Abstract][Full Text] [Related]
14. Survival of MHC-deficient mouse heterotopic cardiac allografts.
Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
[TBL] [Abstract][Full Text] [Related]
15. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
Sheng-Tanner XF; Miller RG
Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
[TBL] [Abstract][Full Text] [Related]
16. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
[TBL] [Abstract][Full Text] [Related]
17. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
[TBL] [Abstract][Full Text] [Related]
18. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
19. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
20. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
